Because of the nature of attention required for patients receiving long-term intravenous care, patients are increasingly preferring to have treatment administered away from the hospital setting, typically at home or at alternative sites. The home infusion therapy market is expected to reach $28.3 billion by 2024, according to a May 2017 report by Grand View Research, Inc. The shift away from hospital settings has increased the care team members needed to coordinate infusion therapy. What used to be a physician, nurse, and patient team has now expanded to include specialtySEE DETAILS